Rchr
J-GLOBAL ID：202101018317475110
Update date: Mar. 15, 2024
kitao akihito
キタオ アキヒト | kitao akihito
Affiliation and department：
Papers (37)：
-
Yuri Hirakawa, Akihito Kitao, Marika Watanabe, Sakuya Matsumoto, Ryohei Komaki, Rina Sakai, Kohei Morimoto, Kimikazu Yakushijin, Hironobu Minami. Irreversible Intrathecal Chemotherapy-induced Myelopathy in a Patient with Diffuse Large B-cell Lymphoma. Internal medicine (Tokyo, Japan). 2024. 63. 4. 547-551
-
Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Takaji Matsutani, Wataru Hojo, Hironori Sakai, Sakuya Matsumoto, Marika Watanabe, Akihito Kitao, Yasuyuki Saito, et al. Response to mRNA SARS-CoV-2 vaccination evaluated by B-cell receptor repertoire after tixagevimab/cilgavimab administration. British journal of haematology. 2023. 202. 3. 504-516
-
Hiroya Ichikawa, Kimikazu Yakushijin, Yoshiharu Miyata, Hirofumi Kanehira, Miki Joyce, Yuri Hirakawa, Sakuya Matsumoto, Shigeki Nagao, Rina Sakai, Keiji Kurata, et al. Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia. eJHaem. 2023
-
Aki Inase, Yimamu Maimaitili, Shiro Kimbara, Yu Mizutani, Yoshiharu Miyata, Shinya Ohata, Hisayuki Matsumoto, Akihito Kitao, Rina Sakai, Koji Kawaguchi, et al. GSK3 inhibitor enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance. EJHaem. 2023. 4. 1. 153-164
-
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, Goh Ohji, Hiroya Ichikawa, Hironori Sakai, Wataru Hojo, Miki Saeki, Yuri Hirakawa, Sakuya Matsumoto, et al. A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients. Vaccines. 2022. 10. 11
ｍore...
MISC (1)：
-
Current status and future direction of the treatment development for breast cancer. 2016. 258. 5. 553-559
Return to Previous Page
